The drugmakers are taking issue with requirements to produce certain data stretching back to 1996, records related to any schedule II opioids and documents produced previously in any litigation involving the marketing or distribution of opioids. Hunter Shkolnik of Napoli Shkolnik PLLC, a top plaintiffs attorney in the MDL, told Law360 that the (defense) parties “must move on and accept these decisions and not delay this trial, something the defendants wish to do.” “This is a defendant's worst nightmare, having a short trial date,” Shkolnik said in April. “They bask in delayed discovery that goes on for years.” The case is In re: National Prescription Opiate Litigation, case number 1:17-md-02804, in the U.S. District Court for the Northern District of Ohio. Download